From: Assessment of bee venom therapy in animal model of statin-induced myopathy
Variable | Control n = 10 | Statin n = 10 | Bee venom n = 10 | Â | P value |
---|---|---|---|---|---|
Turns (no./epoch) | 434.89 ± 96.46 | 599.00 ± 164.28 | 471.43 ± 134.23 | P1 | 0.011* |
P2 | 0.549 | ||||
P3 | 0.043* | ||||
Amplitude (μV) | 410.22 ± 109.08 | 312.90 ± 47.70 | 382.86 ± 114.8 | P1 | 0.031* |
P2 | 0.527 | ||||
P3 | 0.113 | ||||
Turn/amplitude (T/A) ratio | 1.104 ± 0.306 | 1.997 ± 0.74 | 1.3 ± 0.543 | P1 | 0.001* |
P2 | 0.439 | ||||
P3 | 0.1 | ||||
NSS | 338.33 ± 137.74 | 388.60 ± 164.04 | 334.43 ± 104.26 | P1 | 0.421 |
P2 | 0.956 | ||||
P3 | 0.386 | ||||
Activity (%) | 32.67 ± 17.73 | 29.7 ± 12.07 | 29.86 ± 11.02 | P1 | 0.64 |
P2 | 0.66 | ||||
P3 | 0.98 |